Related Experiment Video
Updated: Dec 15, 2025

11:16
A Microfluidic Chip for ICPMS Sample Introduction
Published on: March 5, 2015
11.6K
Programmable µChopper Device with On-Chip Droplet Mergers for Continuous Assay Calibration
Nan Shi1, Christopher J Easley1
1Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849, USA.
Micromachines
|July 8, 2020
Summary
This study introduces an automated microfluidic device for precise real-time control of droplet contents in bioassays. The system enables rapid, cost-effective, and automated analysis using minimal reagents, improving assay efficiency.
Area of Science:
- Microfluidics
- Bioanalytical Chemistry
- Assay Automation
Background:
- Passive droplet microfluidic devices lack real-time control over droplet contents.
- Automated control is crucial for complex bioassays and reducing reagent waste.
Purpose of the Study:
- To develop an automated droplet-based microfluidic device for real-time control and analysis.
- To demonstrate the device's capability for accurate quantification and signal drift correction.
- To validate the system for homogeneous immunoassays with reduced reagent consumption.
Main Methods:
- Development of an automated microfluidic device with pneumatic pumps and salt water electrodes.
- Integration of custom control software for droplet generation and merging.
- Application of the μChopper method for lock-in fluorescence detection and real-time signal correction.
Main Results:
- Successful generation and merging of up to six aqueous-in-oil droplets.
- Real-time correction of analyte-independent signal drifts and excitation light intensity changes.
- Validation with insulin immunoassays achieving low limits of detection (LODconc = 2 ng mL−1, LODamt = 5 amol) in under 1 minute.
- Demonstrated 160-fold cost savings in reagents compared to standard well-plate formats.
Conclusions:
- The developed microfluidic device offers precise, real-time control for automated bioassays.
- The system significantly reduces reagent volume and cost while enhancing assay efficiency.
- This scalable technology is well-suited for assays requiring expensive reagents and real-time automation.

